{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T03:06:34Z","timestamp":1762052794517,"version":"build-2065373602"},"reference-count":76,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF)","doi-asserted-by":"publisher","award":["NRF-2019R1I1A1A01061296","NRF-2021R1I1A1A01040732"],"award-info":[{"award-number":["NRF-2019R1I1A1A01061296","NRF-2021R1I1A1A01040732"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bioengineering"],"abstract":"<jats:p>This study investigates the role of Sygen\u00ae in diabetic peripheral neuropathy, a severe disease that affects the peripheral nervous system in diabetic individuals. This disorder often impacts the lower limbs, causing significant discomfort and, if left untreated, progresses into more serious conditions involving chronic ulcers and even amputation in many cases. Although there are management strategies available, peripheral neuropathies are difficult to treat as they often present multiple causes, especially due to metabolic dysfunction in diabetic individuals. Gangliosides, however, have long been studied and appreciated for their role in neurological diseases. The monosialotetrahexosylganglioside (GM1) ganglioside, popularly known as Sygen, provides beneficial effects such as enhanced neuritic sprouting, neurotrophism, neuroprotection, anti-apoptosis, and anti-excitotoxic activity, being particularly useful in the treatment of neurological complications that arise from diabetes. This product mimics the roles displayed by neurotrophins, improving neuronal function and immunomodulation by attenuating exacerbated inflammation in neurons. Furthermore, Sygen assists in axonal stabilization and keeps nodal and paranodal regions of myelin fibers organized. This maintains an adequate propagation of action potentials and restores standard peripheral nerve function. Given the multifactorial nature of this complicated disorder, medical practitioners must carefully screen the patient to avoid confusion and misdiagnosis. There are several studies analyzing the role of Sygen in neurological disorders. However, the medical literature still needs more robust investigations such as randomized clinical trials regarding the administration of this compound for diabetic peripheral neuropathies, specifically.<\/jats:p>","DOI":"10.3390\/bioengineering9050217","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:59:37Z","timestamp":1652875177000},"page":"217","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Application of Sygen\u00ae in Diabetic Peripheral Neuropathies\u2014A Review of Biological Interactions"],"prefix":"10.3390","volume":"9","author":[{"given":"Marcelo Amaral","family":"Coelho","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-9493","authenticated-orcid":false,"given":"Madhan","family":"Jeyaraman","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Faculty of Medicine-Sri Lalithambigai Medical College and Hospital, Dr MGR Educational and Research Institute, Chennai 600095, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-3326","authenticated-orcid":false,"given":"Naveen","family":"Jeyaraman","sequence":"additional","affiliation":[{"name":"Fellow in Joint Replacement, Department of Orthopaedics, Atlas Hospitals, Tiruchirappalli 620002, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-0854","authenticated-orcid":false,"given":"Ramya Lakshmi","family":"Rajendran","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Atsushi","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Mosaner","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0549-6821","authenticated-orcid":false,"given":"Gabriel Silva","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-0176","authenticated-orcid":false,"given":"Jo\u00e3o Vitor","family":"Bizinotto Lana","sequence":"additional","affiliation":[{"name":"Medical Specialties School Centre, Centro Universit\u00e1rio Max Planck, Indaiatuba 13343-060, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Vit\u00f3ria Santos Duarte","family":"Lana","sequence":"additional","affiliation":[{"name":"Medical Specialties School Centre, Centro Universit\u00e1rio Max Planck, Indaiatuba 13343-060, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-833X","authenticated-orcid":false,"given":"Lucas Furtado","family":"da Fonseca","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"},{"name":"Department of Orthopaedics, The Federal University of S\u00e3o Paulo, S\u00e3o Paulo 04024-002, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Barnab\u00e9","family":"Domingues","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0658-4604","authenticated-orcid":false,"given":"Prakash","family":"Gangadaran","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea"},{"name":"BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-3929","authenticated-orcid":false,"given":"Byeong-Cheol","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea"},{"name":"BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 F\u00e1bio Santos Duarte","family":"Lana","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Brazilian Institute of Regenerative Medicine, Indaiatuba 13334-170, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0972-2327.41875","article-title":"Diagnostic approach to peripheral neuropathy","volume":"11","author":"Misra","year":"2008","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S1474-4422(17)30329-0","article-title":"The diagnostic challenge of small fibre neuropathy: Clinical presentations, evaluations, and causes","volume":"16","author":"Terkelsen","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic Neuropathies: A statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mcna.2013.03.008","article-title":"Epidemiology of Foot Ulceration and Amputation: Can Global Variation be Explained?","volume":"97","author":"Margolis","year":"2013","journal-title":"Med. Clin. North Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.2337\/diacare.28.10.2378","article-title":"Diabetic Peripheral Neuropathy and Depressive Symptoms: The association revisited","volume":"28","author":"Vileikyte","year":"2005","journal-title":"Diabetes Care"},{"key":"ref_8","first-page":"136","article-title":"Diabetic Neuropathy: A Position Statement by the American Diabetes Association","volume":"40","author":"Boulton","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s12035-015-9136-z","article-title":"GM1 Ganglioside: Past Studies and Future Potential","volume":"53","author":"Aureli","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","article-title":"Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications","volume":"14","author":"Sipione","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"(1994). Ganglioside GM1 in acute ischemic stroke. SASS Trial. Stroke, 25, 1141\u20131148.","DOI":"10.1161\/01.STR.25.6.1141"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.50.6.1630","article-title":"Parkinson\u2019s disease Improved function with GMl ganglioside treatment in a randomized placebo-controlled study","volume":"50","author":"Schneider","year":"1998","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S849","DOI":"10.1016\/j.jcot.2020.06.021","article-title":"Metabolic syndrome and subchondral bone alterations: The rise of osteoarthritis\u2014A review","volume":"11","author":"Azzini","year":"2020","journal-title":"J. Clin. Orthop. Trauma"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/ars.2013.5822","article-title":"Mitochondrial Dynamics in Peripheral Neuropathies","volume":"21","author":"Sajic","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4239\/wjd.v6.i3.432","article-title":"Diabetic neuropathic pain: Physiopathology and treatment","volume":"6","author":"Schreiber","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcot.2020.09.006","article-title":"The protective role of glutathione in osteoarthritis","volume":"15","author":"Setti","year":"2020","journal-title":"J. Clin. Orthop. Trauma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/dc09-0101","article-title":"Altered C-Fiber Function as an Indicator of Early Peripheral Neuropathy in Individuals with Impaired Glucose Tolerance","volume":"33","author":"Green","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004010000287","article-title":"Sural nerve fibre pathology in diabetic patients with mild neuropathy: Relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology","volume":"101","author":"Malik","year":"2001","journal-title":"Acta Neuropathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"108856","DOI":"10.1016\/j.diabres.2021.108856","article-title":"Whole plantar nerve conduction study: A new tool for early diagnosis of peripheral diabetic neuropathy","volume":"176","author":"Galiero","year":"2021","journal-title":"Diabetes Res. Clin. Pr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular Risk Factors and Diabetic Neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.metabol.2008.01.004","article-title":"Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot","volume":"57","author":"Pinto","year":"2008","journal-title":"Metabolism"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2008-2385","article-title":"Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy","volume":"94","author":"Doupis","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/dc06-2154","article-title":"Impaired Skin Microvascular Reactivity in Painful Diabetic Neuropathy","volume":"30","author":"Quattrini","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejphar.2011.05.059","article-title":"Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats","volume":"674","author":"Jin","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10286-010-0062-x","article-title":"Cardiovascular autonomic neuropathy and other complications in type 1 diabetes","volume":"20","author":"Fontaine","year":"2010","journal-title":"Clin. Auton. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pain.2010.08.010","article-title":"Sensitized peripheral nociception in experimental diabetes of the rat","volume":"151","author":"Fuchs","year":"2010","journal-title":"Pain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00415-008-0999-z","article-title":"Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy","volume":"255","author":"Said","year":"2008","journal-title":"J. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/eujp.2001.0323","article-title":"Neurobiology of neuropathic pain: Mode of action of anticonvulsants","volume":"6","author":"Dickenson","year":"2002","journal-title":"Eur. J. Pain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1152\/jn.2001.86.2.760","article-title":"Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy","volume":"86","author":"Hall","year":"2001","journal-title":"J. Neurophysiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1152\/jn.01267.2004","article-title":"A-Type Voltage-Gated K+ Currents Influence Firing Properties of Isolectin B4-Positive but Not Isolectin B4-Negative Primary Sensory Neurons","volume":"93","author":"Vydyanathan","year":"2005","journal-title":"J. Neurophysiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0094-1298(02)00066-4","article-title":"Wound healing and diabetes mellitus","volume":"30","author":"Greenhalgh","year":"2003","journal-title":"Clin. Plast. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2929","DOI":"10.1002\/dmrr.2929","article-title":"Dysregulation of wound healing mechanisms in diabetes and the importance of negative pressure wound therapy (NPWT)","volume":"33","author":"Khamaisi","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/dmrr.2397","article-title":"Whither pathogenetic treatments for diabetic polyneuropathy? Patho-genetic Treatments for DSPN","volume":"29","author":"Boulton","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_37","first-page":"CD007543","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Didangelos, T., Karlafti, E., Kotzakioulafi, E., Kontoninas, Z., Margaritidis, C., Giannoulaki, P., and Kantartzis, K. (2020). Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy. Nutrients, 12.","DOI":"10.3390\/nu12113254"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle Intervention for Pre-Diabetic Neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/PPA.S16358","article-title":"Duloxetine in the management of diabetic peripheral neuropathic pain","volume":"5","author":"Boomershine","year":"2011","journal-title":"Patient Prefer. Adherence"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: A literature review","volume":"11","year":"2007","journal-title":"Eur. J. Pain"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Chiricozzi, E., Lunghi, G., Di Biase, E., Fazzari, M., Sonnino, S., and Mauri, L. (2020). GM1 Ganglioside Is a Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030868"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Svennerholm, L., Mandel, P., Dreyfus, H., and Urban, P.-F. (1980). Ganglioside Designation. Structure and Function of Gangliosides, Springer.","DOI":"10.1007\/978-1-4684-7844-0"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jnc.14540","article-title":"Sphingolipids and neuronal degeneration in lysosomal storage disorders","volume":"148","author":"Grassi","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0009-3084(94)02304-2","article-title":"Aggregative properties of gangliosides in solution","volume":"71","author":"Sonnino","year":"1994","journal-title":"Chem. Phys. Lipids"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1471-4159.1993.tb02140.x","article-title":"A Review and Predictive Models of Gang ioside Uptake by Biological Membranes","volume":"61","author":"Saqr","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.7291999","article-title":"Ganglioside Stimulation of Axonal Sprouting in Vitro","volume":"214","author":"Roisen","year":"1981","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jnr.490120204","article-title":"Biology of gangliosides: Neuritogenic and neuronotrophic properties","volume":"12","author":"Ledeen","year":"1984","journal-title":"J. Neurosci. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/00007632-200112151-00015","article-title":"The Sygen\u00ae Multicenter Acute Spinal Cord Injury Study","volume":"26","author":"Geisler","year":"2001","journal-title":"Spine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tibs.2015.04.005","article-title":"The multi-tasked life of GM1 ganglioside, a true factotum of nature","volume":"40","author":"Ledeen","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jnc.14146","article-title":"Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells","volume":"143","author":"Chiricozzi","year":"2017","journal-title":"J. Neurochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fneur.2019.00859","article-title":"Gangliosides: Treatment Avenues in Neurodegenerative","volume":"10","author":"Magistretti","year":"2019","journal-title":"Dis. Front. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-021-02374-x","article-title":"Anti-inflammatory role of GM1 and modulatory effects of gangliosides on microglia functions","volume":"19","author":"Galleguillos","year":"2022","journal-title":"J Neuroinflammation."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0008-8749(87)90173-0","article-title":"Inhibition by gangliosides of the specific binding of lipopolysaccharide (LPS) to human monocytes prevents LPS-induced interleukin-1 production","volume":"106","author":"Cavaillon","year":"1987","journal-title":"Cell. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0165-2478(88)90164-2","article-title":"Gangliosides suppression of murine lymphoproliferation and interleukin 1 production","volume":"19","author":"Jeng","year":"1988","journal-title":"Immunol. Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1017\/S1740925X12000087","article-title":"Brain-derived neurotrophic factor from microglia: A molecular substrate for neuropathic pain","volume":"7","author":"Trang","year":"2011","journal-title":"Neuron Glia Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"429815","DOI":"10.1155\/2013\/429815","article-title":"Microglia Control Neuronal Network Excitability via BDNF Signalling","volume":"2013","author":"Ferrini","year":"2013","journal-title":"Neural Plast."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9042851","DOI":"10.1155\/2017\/9042851","article-title":"Phagocytosis: A Fundamental Process in Immunity","volume":"2017","author":"Rosales","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nn1442","article-title":"Asymmetric membrane ganglioside sialidase activity specifies axonal fate","volume":"8","author":"Hasegawa","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/glycob\/cws103","article-title":"Biosynthesis of the major brain gangliosides GD1a and GT1b","volume":"22","author":"Sturgill","year":"2012","journal-title":"Glycobiology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1471-4159.2006.04319.x","article-title":"Myelin-associated glycoprotein (MAG): Past, present and beyond","volume":"100","author":"Quarles","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1021\/cn900029p","article-title":"Myelin-Associated Glycoprotein (MAG) Protects Neurons from Acute Toxicity Using a Ganglioside-Dependent Mechanism","volume":"1","author":"Mehta","year":"2009","journal-title":"ACS Chem. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2012.05.020","article-title":"CRMP4 mediates MAG-induced inhibition of axonal outgrowth and protection against Vincristine-induced axonal degeneration","volume":"519","author":"Nagai","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Lopez, P.H.H., and B\u00e1ez, B.B. (2018). Gangliosides in Axon Stability and Regeneration. Progress in Molecular Biology and Translational Science, Elsevier.","DOI":"10.1016\/bs.pmbts.2018.03.001"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1523\/JNEUROSCI.4432-13.2014","article-title":"Neu3 Sialidase-Mediated Ganglioside Conversion Is Necessary for Axon Regeneration and Is Blocked in CNS Axons","volume":"34","author":"Kappagantula","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1471-4159.1984.tb02678.x","article-title":"Promotion of Neuritogenesis in Mouse Neuroblastoma Cells by Exogenous Gangliosides. Relationship Between the Effect and the Cell Association of Ganglioside GM1","volume":"42","author":"Facci","year":"1984","journal-title":"J. Neurochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-3806(85)90003-3","article-title":"GM1 ganglioside accelerates neurite outgrowth from primary peripheral and central neurons under selected culture conditions","volume":"23","author":"Skaper","year":"1985","journal-title":"Dev. Brain Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.20503","article-title":"Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers","volume":"55","author":"Susuki","year":"2007","journal-title":"Glia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.expneurol.2005.04.017","article-title":"Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: Neuropathology and behavioral deficits in single- and double-null mice","volume":"195","author":"Pan","year":"2005","journal-title":"Exp. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ymgme.2018.06.014","article-title":"Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation","volume":"124","author":"Trinchera","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/acn3.329","article-title":"Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site","volume":"3","author":"Roda","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e23332","DOI":"10.7554\/eLife.23332","article-title":"Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy","volume":"6","author":"Kleinecke","year":"2017","journal-title":"eLife"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00118","DOI":"10.1042\/AN20130025","article-title":"Node of Ranvier Disruption as a Cause of Neurological Diseases","volume":"5","author":"Susuki","year":"2013","journal-title":"ASN Neuro"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/mus.25273","article-title":"Chronic peripheral nerve compression disrupts paranodal axoglial junctions","volume":"55","author":"Otani","year":"2016","journal-title":"Muscle Nerve"}],"container-title":["Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5354\/9\/5\/217\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:14:06Z","timestamp":1760138046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5354\/9\/5\/217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":76,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["bioengineering9050217"],"URL":"https:\/\/doi.org\/10.3390\/bioengineering9050217","relation":{},"ISSN":["2306-5354"],"issn-type":[{"type":"electronic","value":"2306-5354"}],"subject":[],"published":{"date-parts":[[2022,5,18]]}}}